Many new down- and up-regulatory signaling pathways, from known cancer progression suppressors to matrix metalloproteinases, differ widely in cells of various cancers

Journal of Cellular Physiology

Volumn 224, Issue 2, 2010, Pages 549-558

  DeLassus, Gregory S ^a   Cho, Hyojin ^a   Hoang, Stanley ^a   Eliceiri, George L ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3; CYCLIN DEPENDENT KINASE INHIBITOR 2A; FIBULIN; GELATINASE A; INTERLEUKIN 4; INTERSTITIAL COLLAGENASE; MATRILYSIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 16; MATRIX METALLOPROTEINASE 19; MATRIX METALLOPROTEINASE 25; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P53; UNCLASSIFIED DRUG; UVOMORULIN; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; BRAIN CANCER; BREAST CANCER; CANCER CELL; CANCER GROWTH; CELL DIFFERENTIATION; DOWN REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUNG CANCER; NUCLEOTIDE SEQUENCE; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; UPREGULATION; WILD TYPE; DISEASE COURSE; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOPLASM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

CELL LINE, TUMOR; DISEASE PROGRESSION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASES; NEOPLASMS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 77953634204     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22157     Document Type: Article

References (29)

1. Adachi Y, Chandrasekar N, Kin Y, Lakka SS, Mohanam S, Yanamandra N, Mohan PM, Fuller GN, Fang B, Fueyo J, Dinh DH, Olivero WC, Tamiya T, Ohmoto T, Kyritsis AP, Rao JS. 2002. Suppression of glioma invasion and growth by adenovirus-mediated delivery of a bicistronic construct containing antisense uPAR and sense p16 gene sequences. Oncogene 21:87-95.
2. Bakalova R, Zhelev Z, Ohba H, Baba Y. 2005. Quantum dot-based Western blot technology for ultrasensitive detection of tracer proteins. J Am Chem Soc 127:9328-9329. (Pubitemid 40934721)
3. Cai XM, Tao BB, Wang LY, Liang YL, Jin JW, Yang Y, Hu YL, Zha XL. 2005. Protein phosphatase activity of PTEN inhibited the invasion of glioma cells with epidermal growth factor receptor mutation type III expression. Int J Cancer 117:905-912. (Pubitemid 41688564)
4. DeLassus GS, Cho H, Park J, Eliceiri GL. 2008. New pathway links from cancer-progression determinants to gene expression ofmatrix metalloproteinases in breast cancer cells. J Cell Physiol 217:739-744.
5. Egeblad M, Werb Z. 2002. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2:161-174. (Pubitemid 37328786)
6. Ertel A, Verghese A, Byers S, Ochs M, Tozeren A. 2006. Pathway-specific differences between tumor cell lines and normal and tumor tissue cells. Mol Cancer 5:55-67. (Pubitemid 44742653)
7. Fu Z, Smith PC, Zhang L, Rubin MA, Dunn RL, Yao Z, Keller ET. 2003. Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. J Natl Cancer Inst 95:878-889. (Pubitemid 36833879)
8. Greshock J, Nathanson K, Martin A-M, Zhang L, Coukos G, Weber BL, Zaks TZ. 2007. Cancer cell lines as genetic models of their parent histology: Analyses based on array comparative genomic hybridization. Cancer Res 67:3594-3600. (Pubitemid 46762143)
9. Hegedüs L, Cho H, Xie X, Eliceiri G. 2008. Additional MDA-MB-231 breast cancer cell matrix metalloproteinases promote invasiveness. J Cell Physiol 216:480-485. (Pubitemid 351898476)
10. Hotary K, Li XY, Allen E, Stevens SL, Weiss SJ. 2006. A cancer cell metalloprotease triad regulates the basement membrane transmigration program. Genes Dev 20:2673-2686. (Pubitemid 44498378)
11. Jiang WG, Davies G, Martin TA, Parr C, Watkins G, Mason MD, Mokbel K, Mansel RE. 2005. Targeting matrilysin and its impact on tumor growth in vivo: The potential implications in breast cancer therapy. Clin Cancer Res 11:6012-6019. (Pubitemid 41170333)
12. Jiang W, Davies G, Martin T, Parr C, Watkins G, Mason M, Mansel R. 2006. Expression of membrane type-1 matrix metalloproteinase, MT1-MMP in human breast cancer and its impact on invasiveness of breast cancer cells. Int J Mol Med 17:583-590.
13. Jones S, Zhang X, Parsons DW, Lin JC-H, Leary RJ, Angenendt P, Mankoo P, Carter H, Kamiyama H, Jimeno A, Hong SM, Fu B, Lin MT, Calhoun ES, Kamiyama M, Walter K, Nikolskaya T, Nikolsky Y, Hartigan J, Smith DR, Hidalgo M, Leach SD, Klein AP, Jaffee EM, Goggins M, Maitra A, Iacobuzio-Donahue C, Eshleman JR, Kern SE, Hruban RH, Karchin R, Papadopoulos N, Parmigiani G, Vogelstein B, Velculescu VE, Kinzler KW. 2008. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321:1801-1806.
14. Merrell MA, Ilvesaro JM, Lehtonen N, Sorsa T, Gehrs B, Rosenthal E, Chen D, Shackley B, Harris KW, Selander KS. 2006. Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity. Mol Cancer Res 4:437-447. (Pubitemid 44197039)
15. Muñoz-Najar U, Neurath K, Vumbaca F, Claffey K. 2006. Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activation. Oncogene 25:2379-2392.
16. Pérez-Ruiz M, Collao X, Navarro-Mari JM, Tenorio A. 2007. Reverse transcription, real-time PCR assay for detection of Toscana virus. J Clin Virol 39:276-281. (Pubitemid 47079009)
17. Ross D, Perou C. 2001. A comparison of gene expression signatures from breast tumors and breast tissue derived cell lines. Dis Markers 17:99-109.
18. Sandberg R, Ernberg I. 2005. Assessment of tumor characteristic gene expression in cell lines using a tissue similarity index (TSI). Proc Natl Acad Sci 102:2052-2057.
19. Sawyers C. 2004. Targeted cancer therapy. Nature 432:294-297.
20. Schwartz B, Melnikova VO, Tellez C, Mourad-Zeidan A, Blehm K, Zhao YJ, McCarty M, Adam L, Bar-Eli M. 2007. Loss of AP-2alpha results in deregulation of E-cadherin and MMP-9 and an increase in tumorigenicity of colon cancer cells in vivo. Oncogene 26:4049-4058.
21. Toschi E, Rota R, Antonini A, Melillo G, Capogrossi MC. 2000. Wild-Type p53 gene transfer inhibits invasion and reduces matrix metalloproteinase-2 levels in p53-mutated human melanoma cells. J Invest Dermatol 114:1188-1194.
22. Twal WO, Czirok A, Hegedus B, Knaak C, Chintalapudi MR, Okagawa H, Sugi Y, Argraves WS. 2001. Fibulin-1 suppression of fibronectin-regulated cell adhesion and motility. J Cell Sci 114:4587-4598.
23. Uchiyama A, Essner R, Doi F, Nguyen T, Ramming KP, Nakamura T, Morton DL, Hoon DSB. 1996. Interleukin 4 inhibits hepatocyte growth factor-induced invasion and migration of colon carcinomas. J Cell Biochem 62:443-453.
24. Vogelstein B, Kinzler KW. 2004. Cancer genes and the pathways they control. Nat Med 10:789-799.
25. Wang GK, Zhang W. 2005. The signaling network of tumor invasion. Histol Histopathol 20:593-602.
26. Wong AS, Gumbiner BM. 2003. Adhesion-independent mechanism for suppression of tumor cell invasion by E-cadherin. J Cell Biol 161:1191-1203.
27. Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, Leary RJ, Shen D, Boca SM, Barber T, Ptak J, Silliman N, Szabo S, Dezso Z, Ustyanksky V, Nikolskaya T, Nikolsky Y, Karchin R, Wilson PA, Kaminker JS, Zhang Z, Croshaw R, Willis J, Dawson D, Shipitsin M, Willson JKV, Sukumar S, Polyak K, Park BH, Pethiyagoda CL, Pant PVK, Ballinger DG, Sparks AB, Hartigan J, Smith DR, Suh E, Papadopoulos N, Buckhaults P, Markowitz SD, Parmigiani G, Kinzler KW, Velculescu VE, Vogelstein B. 2007. The genomic landscapes of human breast and colorectal cancers. Science 318:1108-1113. (Pubitemid 350134889)
28. Wyatt CA, Geoghegan JC, Brinckerhoff CE. 2005. Short hairpin RNA-mediated inhibition of matrix metalloproteinase-1 in MDA-231 cells: Effects on matrix destruction and tumor growth. Cancer Res 65:11101-11108.
29. Yan C, Boyd DD. 2007. Regulation of matrix metalloproteinase gene expression. J Cell Physiol 211:19-26.